Q32 Bio (QTTB) EPS (Basic) (QoQ) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Q32 Bio | 162.94 Mn | 112.19 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -111.46% |
| Dec 31, 2025 | 885.00% |
| Sep 30, 2025 | 23.08% |
| Jun 30, 2025 | 13.33% |
| Mar 31, 2025 | 18.92% |
| Dec 31, 2024 | 23.97% |
| Sep 30, 2024 | -2.82% |
| Jun 30, 2024 | -237.86% |
| Mar 31, 2024 | 101.34% |
| Dec 31, 2023 | -90.40% |
| Sep 30, 2023 | -142.78% |
| Jun 30, 2023 | 15.88% |
| Mar 31, 2023 | -3,206.67% |
| Dec 31, 2022 | -1.69% |
| Sep 30, 2022 | -15.69% |
| Jun 30, 2022 | -131.68% |
| Mar 31, 2022 | 372.88% |
| Dec 31, 2021 | -9.26% |
| Sep 30, 2021 | 0.00% |
| Jun 30, 2021 | -2,600.00% |
| Mar 31, 2021 | 96.72% |
| Dec 31, 2020 | 1.61% |
| Sep 30, 2020 | 20.51% |
| Jun 30, 2020 | 0.00% |
| Mar 31, 2020 | -41.82% |
| Dec 31, 2019 | 17.91% |
| Sep 30, 2019 | -9.84% |
| Jun 30, 2019 | 4.69% |
| Mar 31, 2019 | -20.75% |
| Dec 31, 2018 | -39.47% |
| Sep 30, 2018 | -11.76% |
| Jun 30, 2018 | 91.69% |
| Mar 31, 2018 | 12.42% |
| Dec 31, 2017 | -67.99% |
| Sep 30, 2017 | -6.51% |
| Jun 30, 2017 | 6.45% |